Lixte Biotechnology Holdings Inc.

NASDAQ: LIXT
Share price (3/25/25): $1.35
Market cap (3/25/25): $3.037 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 12/31/24 FY 2024

ended 09/30/24 Q3

ended 06/30/24 Q2

ended 03/31/24 Q1

ended 12/31/23 FY 2023

Prospectuses and Registrations Filter

Prospectus supplement for primary offering

Registration withdrawal request

Prospectus supplement for primary offering

Initial registration of new securities – amended

Initial registration of new securities – amended

Ownership Filter

Orca Capital AG

Intracoastal Capital, LLC

Orca Capital AG

Forman Stephen J.

News Filter

Material Definitive Agreement, Financial Statements or Exhibits

Material Definitive Agreement

New Findings Show How LIXTE’s Lead Clinical Compound, LB-100, Is Metabolized to Its Active Form

Adds Northwestern University’s Lurie Cancer Center as Second Site in Ongoing Clinical Trial for Ovarian Clear Cell Cancer

Notice of Delisting, Failure to Satisfy Listing Rule, or Transfer of Listing

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Preliminary proxy

Additional info about upcoming vote

Definitive proxy

Other Filter

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC

Notice of effectiveness

Correspondence with the SEC